Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.38 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.38 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16448820 | 0.94 | AOC3 (0.46) | CA1CA2CA12CA7AOC3 | |
| SCHEMBL16261160 | 0.88 | MEN1 (0.47) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL14672763 | 0.79 | TACR1 (0.42) | EPHX2NR1H4TACR1 | |
| SCHEMBL16017545 | 0.78 | ALDH1A1 (0.43) | MEN1KMT2ACA1CA2AOC3 | |
| SCHEMBL18232499 | 0.78 | EPHX2 (0.60) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL15844016 | 0.78 | TACR1 (0.58) | CA1CA2AOC3ALDH1A1TACR1 | |
| SCHEMBL16259478 | 0.77 | EPHX2 (0.47) | MEN1KMT2ACA1CA2EPHX2 | |
| SCHEMBL2341110 | 0.75 | LMNA (0.47) | MEN1KMT2AEPHX2NR1H4TACR1 | |
| SCHEMBL16261291 | 0.72 | HDAC1 (0.49) | MEN1KMT2AALDH1A1EPHX2TPSAB1 | |
| SCHEMBL26580966 | 0.72 | AOC3 (0.64) | MEN1KMT2ACA1CA2AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9085548-B2 | Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating | NATIONAL TAIWAN UNIVERSITY (TW) | 2015-07-21 | — | — | US | disclosed |
| US-20150051393-A1 | PSEUDOROTAXANES, ROTAXANES AND CATENANES FORMED BY METAL IONS TEMPLATING | NATIONAL TAIWAN UNIVERSITY (TW) | 2015-02-19 | — | — | US | disclosed |
| US-8952167-B2 | Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating | NATIONAL TAIWAN UNIVERSITY (TW) | 2015-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051393-A1 | PSEUDOROTAXANES, ROTAXANES AND CATENANES FORMED BY METAL IONS TEMPLATING | PCNA, TIMCC, SGTA | MEN1 2657/4885KMT2A 2789/4885CA1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.